Jenny Gumperz

Jenny Gumperz

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2009 in PLOS Biology
Verified
Journal Article
Open access
PDF file
LFLisa M. Fox
Lisa M. Fox
DCDaryl G. Cox
Daryl G. Cox
JLJennifer L. Lockridge
Jennifer L. Lockridge
XWXiaohua Wang
Xiaohua Wang
XCXiuxu Chen
Xiuxu Chen
JGJenny Gumperz
Jenny Gumperz
Natural killer T (NKT) cells are a subset of T lymphocytes with potent immunoregulatory properties. Recognition of self-antigens presented by CD1d molecules is an important route of NKT cell activation; however, the molecular identity of specific autoantigens that stimulate human NKT cells remains unclear. Here, we have analyzed human NKT cell recognition of CD1d cellular ligands. The most clearly antigenic species was lyso-phosphatidylcholine (LPC). Diacylated phosphatidylcholine and lyso-phosphoglycerols differing in the chemistry of the head group stimulated only weak responses from human NKT cells. However, lyso-sphingomyelin, which shares the phosphocholine head group of LPC, also activated NKT cells. Antigen-presenting cells pulsed with LPC were capable of stimulating increased cytokine responses by NKT cell clones and by freshly isolated peripheral blood lymphocytes. These results demonstrate that human NKT cells recognize cholinated lyso-phospholipids as antigens presented by CD1d. Since these lyso-phospholipids serve as lipid messengers in normal physiological processes and are present at elevated levels during inflammatory responses, these findings point to a novel link between NKT cells and cellular signaling pathways that are associated with human disease pathophysiology. A central tenet of immunology is that cellular responses that protect us from pathogens result from molecular recognition of foreign compounds (antigens). The role of self-antigens in immune activation is less clear. We show here that an endogenous lipid called lyso-phosphatidylcholine (LPC) is recognized as an antigen by a subpopulation of human T lymphocytes, called natural killer T (NKT) cells, and specifically by the best-studied subgroup of these cells known as invariant NKT (iNKT) cells. NKT cells have attracted the interest of immunologists because they can potently influence the outcome of diverse immune responses; for example, they can promote bacterial clearance and tumor rejection, and they can also quell autoimmune disease pathology. Previous studies indicated that NKT cells are activated by self-antigens, but the identity of the relevant compounds remained unclear. Our finding that LPC is a self-antigen for iNKT cells suggests that these lymphocytes are attuned to highly conserved lipid signaling pathways that are fundamental to normal physiological processes and are markedly up-regulated during inflammation. Thus, these results provide a new molecular basis for understanding how iNKT cells contribute to a wide variety of immune responses.

5 May 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DCDaryl Cox
Daryl Cox
LFLisa Fox
Lisa Fox
RTRunying Tian
Runying Tian
WBWilfried Bardet
Wilfried Bardet
MSMatthew Skaley
Matthew Skaley
WHWilliam Hildebrand
William Hildebrand
CD1 molecules are glycoproteins that present lipid antigens at the cell surface for immunological recognition by specialized populations of T lymphocytes. Prior experimental data suggest a wide variety of lipid species can bind to CD1 molecules, but little is known about the characteristics of cellular ligands that are selected for presentation. Here we have molecularly characterized lipids bound to the human CD1d isoform. Ligands were eluted from secreted CD1d molecules and separated by normal phase HPLC, then characterized by mass spectroscopy. A total of 177 lipid species were molecularly identified, comprising glycerophospholipids and sphingolipids. The glycerophospholipids included common diacylglycerol species, reduced forms known as plasmalogens, lyso-phospholipids (monoacyl species), and cardiolipins (tetraacyl species). The sphingolipids included sphingomyelins and glycosylated forms, such as the ganglioside GM3. These results demonstrate that human CD1d molecules bind a surprising diversity of lipid structures within the secretory pathway, including compounds that have been reported to play roles in cancer, autoimmune diseases, lipid signaling, and cell death.

31 March 2016 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
NZNicholas A. Zumwalde
Nicholas A. Zumwalde
JHJill D. Haag
Jill D. Haag
DSDeepak Sharma
Deepak Sharma
JMJennifer A. Mirrielees
Jennifer A. Mirrielees
LWLee G. Wilke
Lee G. Wilke
JGJenny Gumperz
Jenny Gumperz
Developing strategies to enhance cancer prevention is a paramount goal, particularly given recent concerns about surgical treatment of preinvasive states such as ductal carcinoma in situ. Promoting effective immunosurveillance by leukocytes that scan for nascent neoplastic transformations represents a potential means to achieve this goal. Because most breast cancers arise within the ductal epithelium, enhancing protective immunosurveillance will likely necessitate targeting one or more of the distinctive lymphocyte types found in these sites under normal conditions. Here, we have characterized the intraepithelial lymphocyte compartment of non-cancerous human breast tissue and identified a subset of T lymphocytes that can be pharmacologically targeted to enhance their responses to breast cancer cells. Specifically, Vδ2+ γδ T cells were consistently present in preparations of mammary ductal epithelial organoids and they proliferated in response to zoledronic acid, an aminobisphosphonate drug. Vδ2+ T cells from breast ductal organoids produced the antitumor cytokine IFNγ and efficiently killed bisphosphonate-pulsed breast carcinoma cells. These findings demonstrate the potential for exploiting the ability of Vδ2+ γδ T cells to respond to FDA-approved bisphosphonate drugs as a novel immunotherapeutic approach to inhibit the outgrowth of breast cancers. Cancer Prev Res; 9(4); 305–16. ©2016 AACR.

6 July 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
NZNicholas A. Zumwalde
Nicholas A. Zumwalde
ASAkshat Sharma
Akshat Sharma
XXXuequn Xu
Xuequn Xu
SMShidong Ma
Shidong Ma
CSChristine L. Schneider
Christine L. Schneider
JGJenny Gumperz
Jenny Gumperz
A central issue for adoptive cellular immunotherapy is overcoming immunosuppressive signals to achieve tumor clearance. While γδ T cells are known to be potent cytolytic effectors that can kill a variety of cancers, it is not clear whether they are inhibited by suppressive ligands expressed in tumor microenvironments. Here, we have used a powerful preclinical model where EBV infection drives the de novo generation of human B cell lymphomas in vivo, and autologous T lymphocytes are held in check by PD-1/CTLA-4–mediated inhibition. We show that a single dose of adoptively transferred Vδ2 + T cells has potent antitumor effects, even in the absence of checkpoint blockade or activating compounds. Vδ2 + T cell immunotherapy given within the first 5 days of EBV infection almost completely prevented the outgrowth of tumors. Vδ2 + T cell immunotherapy given more than 3 weeks after infection (after neoplastic transformation is evident) resulted in a dramatic reduction in tumor burden. The immunotherapeutic Vδ2 + T cells maintained low cell surface expression of PD-1 in vivo, and their recruitment to tumors was followed by a decrease in B cells expressing PD-L1 and PD-L2 inhibitory ligands. These results suggest that adoptively transferred PD-1 lo Vδ2 + T cells circumvent the tumor checkpoint environment in vivo.

1 September 2013 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
JLJennifer L. Lockridge
Jennifer L. Lockridge
YZYing Zhou
Ying Zhou
YBYusof A. Becker
Yusof A. Becker
SMShidong Ma
Shidong Ma
SKShannon C. Kenney
Shannon C. Kenney
JGJenny Gumperz
Jenny Gumperz
Chronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoietic stem cell (HSC) transplantation success. Effective treatments for cGVHD have been difficult to develop, in part because of a paucity of animal models that recapitulate the multiorgan pathologies observed in clinical cGVHD. Here we present an analysis of the pathology that occurs in immunodeficient mice engrafted with human fetal HSCs and implanted with fragments of human fetal thymus and liver. Starting at time points generally later than 100 days post-transplantation, the mice developed signs of illness, including multiorgan cellular infiltrates containing human T cells, B cells, and macrophages; fibrosis in sites such as lungs and liver; and thickened skin with alopecia. Experimental manipulations that delayed or reduced the efficiency of the HSC engraftment did not affect the timing or progression of disease manifestations, suggesting that pathology in this model is driven more by factors associated with the engrafted human thymic organoid. Disease progression was typically accompanied by extensive fibrosis and degradation of the thymic organoid, and there was an inverse correlation of disease severity with the frequency of FoxP3(+) thymocytes. Hence, the human thymic tissue may contribute T cells with pathogenic potential, but the generation of regulatory T cells in the thymic organoid may help to control these cells before pathology resembling cGVHD eventually develops. This model thus provides a new system to investigate disease pathophysiology relating to human thymic events and to evaluate treatment strategies to combat multiorgan fibrotic pathology produced by human immune cells.

16 April 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
XWXiaohua Wang
Xiaohua Wang
KBKathleen A. Bishop
Kathleen A. Bishop
SHSubramanya Hegde
Subramanya Hegde
LRLance A. Rodenkirch
Lance A. Rodenkirch
JPJ. Wesley Pike
J. Wesley Pike
JGJenny Gumperz
Jenny Gumperz
Invariant NKT cells (iNKT cells) are innate T lymphocytes that are thought to play an important role in producing an early burst of IFN-γ that promotes successful tumor immunosurveillance and antimicrobial immunity. The cellular activation processes underlying innate IFN-γ production remain poorly understood. We show here that weak T cell receptor (TCR) stimulation that does not directly activate iNKT cell IFN-γ messenger RNA transcription nevertheless induces histone H4 acetylation at specific regions near the IFNG gene locus. This renders the iNKT cells able to produce IFN-γ in an innate manner (i.e., not requiring concurrent TCR stimulation) upon exposure to IL-12 and IL-18. The iNKT cells retain the capacity for innate activation for hours to days after the initial weak TCR stimulation, although their innate responsiveness gradually declines as a function of histone deacetylation. These results explain how iNKT cells are able to mediate rapid innate IFN-γ secretion in a manner that does not require them to undergo permanent TH1 differentiation. Moreover, our results also indicate that iNKT cell motility is maintained during activation by IL-12 and IL-18. Therefore, iNKT cells activated through this pathway can continue to migrate and may thus disseminate the IFN-γ that they produce, which may amplify its impact.